These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 26924520)

  • 21. Clinical Impact of Diabetes Mellitus on Short-Term Outcomes andIn-Hospital Mortality of Cardiac Mechanical Support with Left Ventricular Assist Device (LVAD): A Retrospective Study from a National Database.
    Yassin AS; Subahi A; Adegbala O; Abubakar H; Akintoye E; Ahmed A; Ismail A; Elhag A; Kambal A; Alade A; Shokr M; Weinberger J; Levine D; Afonso L
    Cardiovasc Revasc Med; 2019 Oct; 20(10):883-886. PubMed ID: 30578171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices.
    Uriel N; Naka Y; Colombo PC; Farr M; Pak SW; Cotarlan V; Albu JB; Gallagher D; Mancini D; Ginsberg HN; Jorde UP
    Eur J Heart Fail; 2011 Feb; 13(2):195-9. PubMed ID: 21098576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9-Year Experience.
    Morgan JA; Go PH; Xuereb L; Kaur B; Akrawe S; Nemeh HW; Borgi J; Lanfear DE; Williams CT; Paone G
    Ann Thorac Surg; 2016 Oct; 102(4):1266-73. PubMed ID: 27173072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
    Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
    J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Colombo PC; Yuzefpolskaya M; Fukuhara S; Han J; Kurlansky P; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Aug; 34(8):1024-32. PubMed ID: 25935438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.
    Vest AR; Kennel PJ; Maldonado D; Young JB; Mountis MM; Naka Y; Colombo PC; Mancini DM; Starling RC; Schulze PC
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation.
    Volkovicher N; Kurihara C; Critsinelis A; Kawabori M; Sugiura T; Manon M; Civitello AB; Morgan JA
    J Artif Organs; 2018 Mar; 21(1):31-38. PubMed ID: 28932915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
    Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation.
    Fudim M; Davis ME; Jenkins C; Brown CL; Wigger MA; Stulak JM; Maltais S; Haglund N
    Ann Thorac Surg; 2015 Dec; 100(6):2117-25; discussion 2125-6. PubMed ID: 26338051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caregivers of Patients With Left Ventricular Assist Devices: Possible Impacts on Patients' Mortality and Interagency Registry for Mechanically Assisted Circulatory Support-Defined Morbidity Events.
    Bruce CR; Minard CG; Wilhelms LA; Abraham M; Amione-Guerra J; Pham L; Grogan SD; Trachtenberg B; Smith ML; Bruckner BA; Estep JD; Kostick KM
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28073849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era.
    Atluri P; Goldstone AB; Fairman AS; MacArthur JW; Shudo Y; Cohen JE; Acker AL; Hiesinger W; Howard JL; Acker MA; Woo YJ
    Ann Thorac Surg; 2013 Sep; 96(3):857-63; discussion 863-4. PubMed ID: 23791165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support.
    Kyriakopoulos CP; Taleb I; Tseliou E; Sideris K; Hamouche R; Maneta E; Nelson M; Krauspe E; Selko S; Visker JR; Dranow E; Goodwin ML; Alharethi R; Wever-Pinzon O; Fang JC; Stehlik J; Selzman CH; Hanff TC; Drakos SG
    J Am Heart Assoc; 2024 Jul; 13(14):e032936. PubMed ID: 38989825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes Mellitus Is Not a Risk Factor for Patients Supported With Left Ventricular Assist Device.
    Zhou P; Xiao Z; Zhu P; Nie Z; Pavan D; Zheng S
    Ann Thorac Surg; 2020 May; 109(5):1614-1622. PubMed ID: 31610168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Sparrow CT; Nassif ME; Raymer DS; Novak E; LaRue SJ; Schilling JD
    JACC Heart Fail; 2015 Dec; 3(12):956-64. PubMed ID: 26577618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
    Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.